Notkola I L, Sulkava R, Pekkanen J, Erkinjuntti T, Ehnholm C, Kivinen P, Tuomilehto J, Nissinen A
Department of Public Health and General Practice, University of Kuopio, Finland.
Neuroepidemiology. 1998;17(1):14-20. doi: 10.1159/000026149.
The epsilon 4 allele of the apolipoprotein E (apoE) is associated with Alzheimer's disease (AD) and also with elevated serum total cholesterol and low-density lipoprotein levels. However, the interrelationships between apoE genotype, plasma cholesterol levels and AD risk have been studied very little. We examined the possible role of serum total cholesterol in the pathogenesis of AD in a population-based sample of 444 men, aged 70-89 years, who were survivors of the Finnish cohorts of the Seven Countries Study. Previous high serum cholesterol level (mean level > or = 6.5 mmol/l) was a significant predictor of the prevalence of AD (odds ratio = 3.1; 95% confidence interval = 1.2, 8.5) after controlling for age and the presence of apoE epsilon 4 allele. In men who subsequently developed AD the cholesterol level decreased before the clinical manifestations of AD. We conclude that high serum total cholesterol may be an independent risk factor for AD and some of the effect of the apoE epsilon 4 allele on risk of AD might be mediated through high serum cholesterol.
载脂蛋白E(apoE)的ε4等位基因与阿尔茨海默病(AD)相关,也与血清总胆固醇升高和低密度脂蛋白水平升高有关。然而,apoE基因型、血浆胆固醇水平与AD风险之间的相互关系鲜有研究。我们在一项基于人群的样本研究中,对444名年龄在70 - 89岁的男性进行了检查,这些男性是七国研究芬兰队列的幸存者,以探讨血清总胆固醇在AD发病机制中的可能作用。在控制年龄和apoE ε4等位基因的存在后,既往高血清胆固醇水平(平均水平≥6.5 mmol/l)是AD患病率的显著预测因素(优势比 = 3.1;95%置信区间 = 1.2, 8.5)。在随后发展为AD的男性中,胆固醇水平在AD临床表现出现之前就已下降。我们得出结论,高血清总胆固醇可能是AD的独立危险因素,并且apoE ε4等位基因对AD风险的部分影响可能是通过高血清胆固醇介导的。